Results of a phase II trial of oral bexarotene (Targretin) combined with interferon alfa-2b (Intron-A) for patients with cutaneous T-cell lymphoma Academic Article uri icon

Overview

MeSH Major

  • Antineoplastic Combined Chemotherapy Protocols
  • Lymphoma, T-Cell, Cutaneous
  • Skin Neoplasms

abstract

  • The addition of interferon alfa-2b did not increase the response rate that would have been expected with bexarotene alone.

publication date

  • May 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1002/cncr.22596

PubMed ID

  • 17366595

Additional Document Info

start page

  • 1799

end page

  • 803

volume

  • 109

number

  • 9